Top-News
Professionelle Dienstleistungen USA

Mersana Therapeutics Inc News

Aktie
WKN:  A2DTR7 ISIN:  US59045L1061 US-Symbol:  MRSN
2,41 €
+0,031 €
+1,30%
15.05.24 08:59:17
Handeln Depot/Watchlist
Aktienanzahl *
120,58 Mio.
Marktkapitalisierung *
286,27 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 29.02.2024

Mersana Therapeutics Inc News

04.03.24 - wallstreet:online Zentralredaktion
BB Biotech: 4,23 Prozent Ausschüttung, positive Aussichten und attraktiv bewertet
BB Biotech-​Aktien haben im Zuge der steigenden Zinsen an Wert verloren. Aktuell deutet vieles auf eine Marktstabilisierung hin. Im März 2024 schüttet das Unternehmen abermals ...
18.08.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN PR Newswire
10.08.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN PR Newswire
04.08.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN PR Newswire
17.07.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN PR Newswire
12.07.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN PR Newswire
28.06.23 - PR Newswire
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Mersana Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: MRSN)
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Mersana Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: MRSN) PR ...
27.06.23 - PR Newswire
MRSN FRAUD ALERT: Jakubowitz Law is Investigating Mersana Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws
MRSN FRAUD ALERT: Jakubowitz Law is Investigating Mersana Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire
26.06.23 - PR Newswire
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Mersana Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: MRSN)
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Mersana Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: MRSN) PR ...
26.06.23 - PR Newswire
MRSN ALERT: The Law Offices of Vincent Wong Investigate Mersana Therapeutics, Inc. for Potential Violations of Securities Laws
MRSN ALERT: The Law Offices of Vincent Wong Investigate Mersana Therapeutics, Inc. for Potential Violations of Securities Laws PR Newswire
23.06.23 - PR Newswire
MRSN FRAUD ALERT: Jakubowitz Law is Investigating Mersana Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws
MRSN FRAUD ALERT: Jakubowitz Law is Investigating Mersana Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire
22.06.23 - PR Newswire
MSN ALERT: The Law Offices of Vincent Wong Investigate Mersana Therapeutics, Inc. for Potential Violations of Securities Laws
MSN ALERT: The Law Offices of Vincent Wong Investigate Mersana Therapeutics, Inc. for Potential Violations of Securities Laws PR Newswire
21.06.23 - PR Newswire
MRSN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Mersana Therapeutics, Inc.
MRSN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Mersana Therapeutics, Inc. PR ...
15.06.23 - Der Aktionär
Mersana‑Aktie crasht nach Horror‑Nachricht – AKTIONÄR‑Tipp schießt hoch
15.06.23 - PR Newswire
Thinking about buying stock in Ideanomics, Bitdeer Technologies, Rivian Automotive, Nikola Corp, or Mersana Therapeutics?
Thinking about buying stock in Ideanomics, Bitdeer Technologies, Rivian Automotive, Nikola Corp, or Mersana Therapeutics? PR Newswire
14.06.23 - PR Newswire
Thinking about trading options or stock in Microsoft, Netflix, Mersana Therapeutics, Tesla, or Alibaba Group Holding?
Thinking about trading options or stock in Microsoft, Netflix, Mersana Therapeutics, Tesla, or Alibaba Group Holding? PR Newswire
06.06.23 - LYNX Analysen
Mersana Therapeutics: Diese Biotech-Aktie hebt gerade ordentlich ab
Im gestrigen LYNX Live-​Trading-Webinar haben wir ein vielversprechendes Biotechnologieunternehmen besprochen, das sich auf die Krebsbehandlung spezialisiert hat. Jetzt ...
03.05.23 - PR Newswire
Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals?
Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? PR Newswire
09.08.22 - PR Newswire
Thinking about buying stock in Ontrak, AMC Entertainment, Mersana Therapeutics, Plug Power, or Verona Pharma?
Thinking about buying stock in Ontrak, AMC Entertainment, Mersana Therapeutics, Plug Power, or Verona Pharma? PR Newswire
19.05.22 - PR Newswire
Thinking about buying stock in Indaptus Therapeutics, Canaan, Tonix Pharmaceuticals, Xos, or Mersana Therapeutics?
Thinking about buying stock in Indaptus Therapeutics, Canaan, Tonix Pharmaceuticals, Xos, or Mersana Therapeutics? PR Newswire

Newssuche

Videos

newspaper
14.05.24 -16,04%
Technical Trading: DAX dienstags Long
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »